Selected
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
2645 results found
2023 ∙ Song, T. J. Shin, J. I. Yon, D. K. Lee, S. W. Hwang, S. Y. Hwang, J. Park, S. H. Lee, S. B. Lee, M. H. Kim, M. S. Koyanagi, A. Tizaoui, K. Kim, J. H. Smith, L.
Cerebral venous thrombosis after ChAdOx1 nCoV-19 vaccination: a systematic review
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Cinconze, E. Rosillon, D. Rappuoli, R. Vadivelu, K. Bekkat-Berkani, R. Abbing-Karahagopian, V.
Challenges in synthesis of real-world vaccine effects on meningococcal serogroup B disease for 4CMenB vaccine post-licensure effectiveness studies: A systematic review
  • Newborn
  • Children
  • Adolescents
  • Adults
  • Meningococcal disease
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Albakri, K. Abdelwahab, O. A. Gabra, M. D. Nafady, M. H. Alabdallat, Y. J. Soliman, A. Cadri, S. Hanaqtah, B. Albazee, E.
Characteristics of sudden hearing loss after different COVID-19 vaccinations: a systematic review and meta-analysis
  • Vaccine/vaccination
  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Rosca, E. C. Bilavu, R. Cornea, A. Simu, M.
Chorea following SARS-CoV-2 infection and vaccination: a systematic review of reported cases
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Alijanzadeh, D. Soltani, A. Afra, F. Salmanpour, F. Loghman, A. H. Samieefar, N. Rezaei, N.
Clinical characteristics and prognosis of temporary miller fisher syndrome following COVID-19 vaccination: a systematic review of case studies
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Tayebi, A. H. Samimisedeh, P. Jafari Afshar, E. Ayati, A. Ghalehnovi, E. Foroutani, L. Abbasi Khoshsirat, N. Rastad, H.
Clinical features and outcomes of Myasthenia Gravis associated with COVID-19 vaccines: A systematic review and pooled analysis
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Tayebi, A. H. Samimisedeh, P. Jafari Afshar, E. Ayati, A. Ghalehnovi, E. Foroutani, L. Abbasi Khoshsirat, N. Rastad, H.
Clinical features and outcomes of Myasthenia Gravis associated with COVID-19 vaccines: A systematic review and pooled analysis
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Zhou, H. Ye, Q.
Clinical Features of COVID-19 Vaccine-Associated Autoimmune Hepatitis: A Systematic Review
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Chenchula, S. Amerneni, K. C. Ghanta, M. K. Padmavathi, R. Chandra, M. B. Adusumilli, M. B. Chavan, M. Mudda, S. Gupta, R. Lakhawat, B.
Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Fortier, L. M. Smith, K. L. Ina, J. G. Sinkler, M. A. Calcei, J. G. Salata, M. J. Gillespie, R. Voos, J. E.
Common Characteristics of Shoulder Injury Related to Vaccine Administration (SIRVA) Following COVID-19 Vaccination: A Comprehensive Systematic Review
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low